RB1 and hepatocellular carcinoma: The loss of function of retinoblastoma (Rb) protein is significant during liver carcinogenesis, and the Rb-negative status of hepatocellular carcinoma (HCC) cells promotes ferroptosis on sorafenib treatment (163).